ARCHIVES

In Brief: ACS Seeking Candidate for Holleb Replacement; NCI To Recruit AD For Biological Carcinogenesis

This article is from The Cancer Letter archive.

Vol. 13 No. 11 | March 13, 1987

Download PDF Visit The Full Archive

Related Articles

NCI Clarifies IRPG Application Receipt, Funding Policies

September 3, 1993

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal

November 4, 1983

NCI Chief Operating Officer Lawrence Ray To Retire

April 24, 2009

SEC Investigating Bristol-Myers’ Sales Statements

July 12, 2002

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005